ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Bile acid receptor;AltName: Full=Farnesoid X-activated receptor;AltName: Full=Farnesol receptor HRR-1;AltName: Full=Nuclear receptor subfamily 1 group H member 4;AltName: Full=Retinoid X receptor-interacting protein 14; Short=RXR-int | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
488
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:23077
Seol W, et al., Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol Endocrinol. 1995 Jan;9(1):72-85
J:64792 Sinal CJ, et al., Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell. 2000 Sep 15;102(6):731-44 J:77878 Cui J, et al., The amino Acid residues asparagine 354 and isoleucine 372 of human farnesoid x receptor confer the receptor with high sensitivity to chenodeoxycholate. J Biol Chem. 2002 Jul 19;277(29):25963-9 J:81724 Lambert G, et al., The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis. J Biol Chem. 2003 Jan 24;278(4):2563-70 J:87780 Zhang Y, et al., Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 2004 Jan 15;18(2):157-69 J:105654 Zhang Y, et al., Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1006-11 J:107133 Inagaki T, et al., Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5 J:107809 Ma K, et al., Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006 Apr;116(4):1102-9 J:110560 Cariou B, et al., The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem. 2006 Apr 21;281(16):11039-49 J:120199 Watanabe M, et al., Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest. 2004 May;113(10):1408-18 J:129677 Inagaki T, et al., Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005 Oct;2(4):217-25 J:142094 Modica S, et al., Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 2008 Dec 1;68(23):9589-94 J:143606 Fang S, et al., The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP. J Biol Chem. 2008 Dec 12;283(50):35086-95 J:154989 Miao J, et al., Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis. Mol Cell Biol. 2009 Dec;29(23):6170-81 J:155433 Kemper JK, et al., FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 2009 Nov;10(5):392-404 J:157174 Vavassori P, et al., The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol. 2009 Nov 15;183(10):6251-61 J:161322 Popescu IR, et al., The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity. FEBS Lett. 2010 Jul 2;584(13):2845-51 J:173426 Chong HK, et al., Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1. Nucleic Acids Res. 2010 Oct;38(18):6007-17 J:178263 Chennamsetty I, et al., Farnesoid X receptor represses hepatic human APOA gene expression. J Clin Invest. 2011 Sep 1;121(9):3724-34 J:195920 Renga B, et al., The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. PLoS One. 2013;8(1):e54472 J:219776 de Aguiar Vallim TQ, et al., MAFG is a transcriptional repressor of bile acid synthesis and metabolism. Cell Metab. 2015 Feb 3;21(2):298-310 J:228417 Claudel T, et al., Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology. 2003 Aug;125(2):544-55 J:228561 Wang YD, et al., Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology. 2008 Nov;48(5):1632-43 J:228635 Gadaleta RM, et al., Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut. 2011 Apr;60(4):463-72 J:234054 Fu T, et al., FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of beta-Klotho. Mol Endocrinol. 2016 Jan;30(1):92-103 J:319839 Modica S, et al., Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology. 2012 Feb;142(2):355-65.e1-4 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/18/2025 MGI 6.24 |
![]() |
|